BACKGROUND: Panic disorder (PD) is hypothesized to be associated with altered function of the major inhibitory neurotransmitter, gamma-aminobutyric acid (GABA). Previous proton magnetic resonance spectroscopy (MRS) studies found lower GABA concentrations in the occipital cortex of subjects with PD relative to healthy control subjects. The current study is the first MRS study to compare GABA concentrations between unmedicated PD subjects and control subjects in the prefrontal cortex (PFC). METHODS: Unmedicated subjects with PD (n = 17) and age- and sex-matched healthy control subjects (n = 17) were scanned on a 3 Tesla scanner using a transmit-receive head coil that provided a sufficiently homogenous radiofrequency field to obtain spectroscopic measurements in the dorsomedial/dorsal anterolateral and ventromedial areas of the PFC. RESULTS: The prefrontal cortical GABA concentrations did not differ significantly between PD subjects and control subjects. There also was no statistically significant difference in glutamate/glutamine (Glx), choline, or N-acetyl aspartate concentrations. CONCLUSIONS: The previously reported finding of reduced GABA concentrations in the occipital cortex of PD subjects does not appear to extend to the PFC.
BACKGROUND:Panic disorder (PD) is hypothesized to be associated with altered function of the major inhibitory neurotransmitter, gamma-aminobutyric acid (GABA). Previous proton magnetic resonance spectroscopy (MRS) studies found lower GABA concentrations in the occipital cortex of subjects with PD relative to healthy control subjects. The current study is the first MRS study to compare GABA concentrations between unmedicated PD subjects and control subjects in the prefrontal cortex (PFC). METHODS: Unmedicated subjects with PD (n = 17) and age- and sex-matched healthy control subjects (n = 17) were scanned on a 3 Tesla scanner using a transmit-receive head coil that provided a sufficiently homogenous radiofrequency field to obtain spectroscopic measurements in the dorsomedial/dorsal anterolateral and ventromedial areas of the PFC. RESULTS: The prefrontal cortical GABA concentrations did not differ significantly between PD subjects and control subjects. There also was no statistically significant difference in glutamate/glutamine (Glx), choline, or N-acetyl aspartate concentrations. CONCLUSIONS: The previously reported finding of reduced GABA concentrations in the occipital cortex of PD subjects does not appear to extend to the PFC.
Authors: G Sanacora; G F Mason; D L Rothman; K L Behar; F Hyder; O A Petroff; R M Berman; D S Charney; J H Krystal Journal: Arch Gen Psychiatry Date: 1999-11
Authors: Paul E Sijens; Tom den Heijer; Daniela Origgi; Sarah E Vermeer; Monique M B Breteler; Albert Hofman; Matthijs Oudkerk Journal: Radiology Date: 2003-01-24 Impact factor: 11.105
Authors: Gerard Sanacora; Ralitza Gueorguieva; C Neill Epperson; Yu-Te Wu; Michael Appel; Douglas L Rothman; John H Krystal; Graeme F Mason Journal: Arch Gen Psychiatry Date: 2004-07
Authors: Zubin Bhagwagar; Marzena Wylezinska; Matthew Taylor; Peter Jezzard; Paul M Matthews; Philip J Cowen Journal: Am J Psychiatry Date: 2004-02 Impact factor: 18.112
Authors: C Neill Epperson; Kristin Haga; Graeme F Mason; Edward Sellers; Ralitza Gueorguieva; Wenjiang Zhang; Erica Weiss; Douglas L Rothman; John H Krystal Journal: Arch Gen Psychiatry Date: 2002-09
Authors: Thomas Dresler; Anne Guhn; Sara V Tupak; Ann-Christine Ehlis; Martin J Herrmann; Andreas J Fallgatter; Jürgen Deckert; Katharina Domschke Journal: J Neural Transm (Vienna) Date: 2012-06-13 Impact factor: 3.575
Authors: Giacomo Salvadore; Jan Willem van der Veen; Yan Zhang; Stefano Marenco; Rodrigo Machado-Vieira; Jacqueline Baumann; Lobna A Ibrahim; David A Luckenbaugh; Jun Shen; Wayne C Drevets; Carlos A Zarate Journal: Int J Neuropsychopharmacol Date: 2011-11-01 Impact factor: 5.176
Authors: Isabelle M Rosso; Melissa R Weiner; David J Crowley; Marisa M Silveri; Scott L Rauch; J Eric Jensen Journal: Depress Anxiety Date: 2013-07-16 Impact factor: 6.505